Pfizer (PFE) Total Liabilities (2009 - 2026)

Pfizer has disclosed Total Liabilities across 18 years of filings, most recently posting $117.2 billion for Q1 2026.

• In Q1 2026, Total Liabilities changed 0.15% year-over-year to $117.2 billion; the TTM figure through Mar 2026 stood at $117.2 billion (changed 0.15% YoY), while the FY2025 annual figure was $121.4 billion, down 2.81% from the prior year.
• Total Liabilities declined to $117.2 billion in Q1 2026, from $121.4 billion in the prior quarter.
• Over the last five years, Total Liabilities for PFE reached as high as $137.2 billion in Q4 2023 and fell as low as $22.5 billion in Q4 2022.
• The 5-year median for Total Liabilities is $117.4 billion (2025), against an average of $111.8 billion.
• Annual changes were most pronounced in 2023 — Total Liabilities soared 424.68% — and 2024, when it fell 8.97%.
• A 5-year view of Total Liabilities shows it stood at $101.3 billion in 2022, then surged by 35.47% to $137.2 billion in 2023, then slipped by 8.97% to $124.9 billion in 2024, then declined by 2.81% to $121.4 billion in 2025, then slipped by 3.44% to $117.2 billion in 2026.
• According to Business Quant data, Total Liabilities over the past three periods registered $117.2 billion, $121.4 billion, and $115.6 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.